Data / Form D filings / XiltriX North America, LLC
XiltriX North America, LLC: Form D filings
XiltriX North America, LLC, a biotechnology company in San Diego, CA, filed 8 Form D notices with the SEC between 2019 and 2026. The latest, on August 26, 2026, reports $3 million sold of a $3 million offering to 20 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 9255 Towne Center Drive Suite 925, San Diego, CA, 92121
- Phone
- (858) 208-0368
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1777611
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 26, 2026 | New notice | $3,000,000 | $3,000,000 | 20 | Aug 13, 2026 | sec.gov | |
| Dec 9, 2024 | New notice | $2,110,653 | $2,110,653 | 18 | Nov 26, 2024 | sec.gov | |
| Feb 14, 2024 | New notice | $2,499,999 | $2,499,999 | 18 | Feb 8, 2024 | sec.gov | |
| Feb 1, 2023 | New notice | $3,500,001 | $2,760,711 | $739,290 | 15 | Jan 18, 2023 | sec.gov |
| Nov 29, 2021 | New notice | $3,750,000 | $3,750,000 | 12 | Nov 17, 2021 | sec.gov | |
| Sep 23, 2020 | New notice | $4,275,000 | $4,275,000 | 10 | Sep 22, 2020 | sec.gov | |
| May 29, 2019 | Amendment | $4,200,000 | $4,200,000 | 11 | May 15, 2019 | sec.gov | |
| May 24, 2019 | New notice | $4,200,000 | $4,200,000 | 11 | May 15, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Moises Eilemberg | Executive Officer, Director | |
| Erik van Stek | Director | |
| Hendrik Hanselaar | Director | |
| Michael O'Connell | Director | |
| Nathaniel Paige | Director | |
| Doron Lurie | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Aug 24, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what XiltriX North America, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.